Literature DB >> 4188606

Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia.

Z A Zawadzki, T G Benedek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4188606     DOI: 10.1002/art.1780120603

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

1.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

Review 2.  Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Keigo Ikeda; Iwao Sekikawa; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Differences in serum IgG structure in health and rheumatoid disease. Circular dichroism studies.

Authors:  P M Johnson; J Watkins; P M Scopes; B M Tracey
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

4.  Monoclonal gammopathies in Japanese patients with Sjögren's syndrome.

Authors:  S Sugai; S Shimizu; Y Hirose; T Takiguchi; S Konda; H Yamano
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

5.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome.

Authors:  L G Anderson; N Talal
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

6.  Prognostic significance of paraproteinaemia in rheumatoid arthritis.

Authors:  C Kelly; G Baird; H Foster; H Hosker; I Griffiths
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.